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We have demonstrated in a previous study that a high degree of worry in patients with gen-
eralized anxiety disorder (GAD) correlates positively with intelligence and that a low degree
of worry in healthy subjects correlates positively with intelligence. We have also shown
that both worry and intelligence exhibit an inverse correlation with certain metabolites in
the subcortical white matter. Here we re-examine the relationships among generalized anx-
iety, worry, intelligence, and subcortical white matter metabolism in an extended sample.
Results from the original study were combined with results from a second study to create
a sample comprised of 26 patients with GAD and 18 healthy volunteers. Subjects were
evaluated using the Penn StateWorry Questionnaire, theWechsler Brief intelligence quo-
tient (IQ) assessment, and proton magnetic resonance spectroscopic imaging (1H-MRSI)
to measure subcortical white matter metabolism of choline and related compounds (CHO).
Patients with GAD exhibited higher IQ’s and lower metabolite concentrations of CHO in
the subcortical white matter in comparison to healthy volunteers. When data from GAD
patients and healthy controls were combined, relatively low CHO predicted both relatively
higher IQ and worry scores. Relatively high anxiety in patients with GAD predicted high IQ
whereas relatively low anxiety in controls also predicted high IQ. That is, the relationship
between anxiety and intelligence was positive in GAD patients but inverse in healthy vol-
unteers. The collective data suggest that both worry and intelligence are characterized by
depletion of metabolic substrate in the subcortical white matter and that intelligence may
have co-evolved with worry in humans.
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INTRODUCTION
Humans are the most intelligent species and also appear to suf-
fer disproportionately from psychopathology. One parameter that
potentially contributes to both intelligence and psychopathol-
ogy is that of “connectivity” between neurons, which putatively
enhances neural processing capacity independent of brain size
(Jerison, 1977). The white matter of the brain, which contains
tracts of myelinated axons, is dedicated solely to facilitating this
connectivity. It appears likely that white matter, though devoid
of neuronal cell bodies, participates in neural processing through
axonal gap junctions (Hamzei-Sichani et al., 2007). Several studies
have noted a positive correlation between white matter volume
and intelligence at the level of whole brain white matter vol-
ume as well as in speciﬁc white matter regions (for example,
see Haier et al., 2004). Schoenemann et al. (2005) have further-
more suggested that white matter plays an important role in the
evolution of the human brain by demonstrating that prefrontal
white matter volume is disproportionately large in humans com-
pared to non-human primates. It should be noted, however, that
the conclusions reached by the authors regarding white matter
volumedifferenceswere subsequently questioned (Sherwood et al.,
2005).
In a previous study (Coplan et al., 2006), we explored associ-
ations among generalized anxiety, worry, intelligence, and brain
metabolite concentrations within the centrum semiovale (CSO)
white matter. The CSO was selected as a region of interest (ROI)
because it comprises the central white matter core of the cerebral
hemispheres. Tissue concentrations of three metabolites – N -
acetyl-aspartate (NAA), a putative marker of neuronal integrity
or density; choline-containing compounds (CHO), reﬂective of
membrane turnover; and creatine+ phosphocreatine (CR), his-
torically used as a stable measure for MRS ratio analyses – were
quantiﬁed using proton magnetic resonance spectroscopic imag-
ing (1H-MRSI). Whereas previous studies had positively linked
prefrontal cortex NAA concentrations to intelligence in healthy
subjects (Valenzuela et al., 2000; Pﬂeiderer et al., 2004; Jung et al.,
2005; Ross et al., 2005),we did not ﬁnd a relationship betweenCSO
NAA concentrations and intelligence quotient (IQ; Hays et al.,
2002). Nor did we detect a relationship between CSO NAA con-
centrations and worry. We did, however, demonstrate that both
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worry and IQ correlate inversely with choline-containing com-
pounds in the white matter CSO. It had previously been posited
that lowCHO represents a depletion of metabolic substrate (Daw-
son et al., 1985; Duc et al., 1997). Thus the data were interpreted
to suggest that both high IQ and high worry are characterized by
enhanced metabolism of the white matter CSO.
In the same study, the association between IQ and worry was
especially intriguing. The relationship between intelligence and
anxiety has been heavily explored. As far back as Spielberger
(1958) noted a negative correlation between intelligence and anx-
iety in healthy subjects. This relationship has been explained as
follows: individuals exhibiting low intelligence are unable to make
responses that lead to success, which in turn results in the devel-
opment of anxiety (Phillips et al., 1960). Others have suggested a
positive correlation between intelligence and pathological anx-
iety based on the hypothesis that gifted children are prone to
disharmonious development, which may result in the develop-
ment of personality disorders, obsessional behavior, and anxiety
disorders. According to Catheline-Antipoff and Poinso (1994),
“the higher the IQ is, the greater the psychological fragility.” In
our study, healthy volunteers exhibited an inverse relationship
between IQ and worry. In contrast, in patients with DSM-IV-
diagnosed generalized anxiety disorder (GAD; First et al., 1995),
IQ correlated positively with worry scores on the Penn StateWorry
Questionnaire (PSWQ; Behar et al., 2003). Thus, high intelligence
was associated with either the least or greatest degree of worry,
depending on whether or not the subject carried a diagnosis
of GAD.
Several factors limited the interpretability of the study results.
First, the original sample size was small (n = 15 for the control
group and n = 15 for the GAD group). The sample size was fur-
ther reduced after two subjects from theGADgroupwere excluded
(one patient exhibited an IQ that was >4 SDs outside the group
mean and IQ scores weremissing for one patient). Additionally, six
subjects in theGADgroupwhohad experienced early traumawere
excluded from analysis of CSO white matter metabolism after it
was noted that the presence of early trauma signiﬁcantly modiﬁed
theMRSImetabolite proﬁle of GADpatients. Further, recruitment
bias may have resulted in a sample of GAD patients that exhibited
signiﬁcantly higher intelligence in comparison to the sample of
healthy volunteers.
In order to further explore the association between salutary
humandevelopment (i.e., intelligence) andpsychiatric symptoma-
tology,we re-examine the relationships among generalized anxiety,
worry, intelligence,andbrainmetabolite concentrationswithin the
CSO white matter in an extended sample of patients with GAD
and healthy controls.
MATERIALS AND METHODS
SUBJECTS
Eighteen healthy volunteers (eight males and 10 females) and 26
patients with GAD (12 males and 14 females) served as sub-
jects. The sample comprised patients from the original, above-
mentioned study (Study #1; Coplan et al., 2006) with the addition
of patients from a second study (Study #2; Mathew et al., 2008).
From the original study, this represents an increase in sample size
of 20% for the control group and 73% for the GAD group (and
an increase of 100% for the GAD group when excluding subjects
with early trauma).
Non-psychiatrically ill controls were required to have a nega-
tive family history in ﬁrst-degree relatives, and were matched for
handedness in the ﬁrst study (all were right-handed) and three
patients and one control were left-handed for the second study. As
determined by the Structured Clinical Interview for DSM-IV Axis
I Disorders as described by First et al. (1995), comorbid disorders
in the GAD group were dysthymia (n= 9), social anxiety disorder
(n= 3), panic disorder with or without agoraphobia (n = 6), and
concurrent social anxiety disorder with dysthymia (n= 1). Inclu-
sion criteria required that GAD precede onset of comorbid Axis
I Disorders. Exclusion criteria were a major depressive episode or
substance abuse within 6months of study entry; a lifetime history
of psychotic, bipolar, obsessive–compulsive, post-traumatic stress,
or eating disorder; substance dependence (other than nicotine);
mental retardation or learning disability; autism; or signiﬁcant
medical or neurological conditions. Of the GAD patients, 21 were
medication-naive, and no subject had psychotropic exposure at
least 4 weeks before scanning. Symptom severity, for the purposes
of the current study,wasmeasured at the time of theMRSI scan by
the PSWQ. In order to evaluate the potential contribution of early
life physical and sexual abuse to MRSI measures, subjects were
systematically assessed using a modiﬁed version of the self-report
early trauma inventory (ETI; Bremner et al., 2000). Eight of 26
(31%) of our GAD patients had suffered severe prepubertal phys-
ical and/or sexual abuse but had not developed post-traumatic
stress disorder (PTSD). The Wechsler abbreviated scale of intel-
ligence (WASI), a brief IQ test, with high concordance rates to
other IQ tests (Hays et al., 2002), was applied to all participants.
Although an IQ< 70 was an exclusion criteria for participation in
the studies, one patient subject with GAD had an IQ of 71 which
was >4 SD outside the total IQ mean and was excluded. All sub-
jects gave written signed informed consent after a complete verbal
and written explanation of the procedures, and the protocol was
approved by the Institutional Review Boards of Columbia Univer-
sity and the New York State Psychiatric Institute and Mount Sinai
Medical Center.
1H-MRSI DATA ACQUISITION
Scans were performed on two separate 1.5 T GE Signa scanners,
using the multi-slice 1H-MRS imaging sequence (Duyn et al.,
1993) as previously described (Mathew et al., 2004). Following
Sagittal scout images, a four-section T1-weighted axial/oblique
localizer image, angulated parallel to the Sylvian ﬁssure, was
acquired, with a slice thickness of 15mm and an inter-slice
gap of 3.5mm, matching the subsequent 1H-MRS scan. Next,
a multi-slice MRSI scan was performed, which is a standard
slice-interleaved spin echo sequence, except that it uses octago-
nally tailored outer volume presaturation pulses to suppress the
strong lipid and fat signals from the scalp, skull, and calvarial
marrow. Water suppression was achieved with a water-selective
radiofrequency pulse followed by strong spoiler gradients. Since
the major metabolite of interest [CHO] has a relatively long
transverse relaxation times in the main ROI, a long echo time
(TE= 280ms) was used tominimize baseline distortion and spec-
tral overlap, thereby facilitating ﬁtting. The other acquisition
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parameters were: TR= 2300ms, FOV= 240mm, 32× 32 phase-
encoding steps with circular k-space sampling, and 256 points
along the signal acquisition domain. The resulting nominal MRSI
voxel sizes were 1.5 cm× 0.75 cm× 0.75 cm, or 0.84 cc.
1H-MRSI DATA ANALYSIS
The MRSI data were transferred to an off-line workstation for
processing and analysis by two of the study investigators, who
used interactive analysis software of their own design. A sin-
gle researcher blinded to diagnosis selected the ROI’s and per-
formed spectral analysis.Another investigator,DikomaC. Shungu,
who is the senior spectroscopist, ensured that the analyses were
performed properly but was not actively involved in ROI selec-
tion or data analysis. The raw data were sorted by slice, zero-
ﬁlled twice along the acquisition domain (to 1024 sampling
points), ﬁltered with a Hamming window along spatial domains,
and then processed by standard three-dimensional fast Fourier
transformation to yield an array of 32× 32 spectra. The spec-
tral data were automatically corrected for susceptibility shifts
due to slight variations in magnetic ﬁeld strength across the
brain using a computer routine that aligned the spectra by
maximizing the cross correlation between a spectrum in the
data matrix and a representative high SNR reference spectrum
selected from the same data matrix. MRSI voxels that best cov-
ered the primary ROIs (right and left CSO) in each subject
were selected on the basis of voxel location on the matching
high-resolution MR localizer images (Figure 1). In each voxel,
the CHO metabolite peak area was obtained using a frequency-
domain Levenberg–Marquardt non-linear least-squares ﬁtting
algorithm. As many pixels as possible were ﬁtted within each
ROI and then averaged. Voxels with poor spectral resolution
(unresolved CHO peaks at 3.22 ppm) were excluded. The num-
ber of voxels rejected varied from subject to subject and did
not result in any patient being rejected. The mean of the
peak areas for CHO and metabolites within an ROI was com-
puted.
ABSOLUTE METABOLITE QUANTITATION
Mean regional peak areas derived from spectral ﬁtting were con-
verted to absolute metabolite concentrations using the phantom
replacement methodology (Soher et al., 1996), which has been
shown to give values that are in excellent agreement with the
literature (Kreis et al., 1993). For further discussion of this quan-
tiﬁcation method, see Mathew et al. (2008, 2010). A Microsoft
Excel worksheet was developed for facilitating the derivation
of absolute CHO metabolite concentrations from spectral peak
areas. The user simply inputted the mean regional peak area
values and the appropriate spectral intensity correction para-
meters for both the phantom and metabolites, and the software
calculated and tabulated the corresponding absolute metabolite
concentrations.
STATISTICAL ANALYSES
Independent t -test comparedGADpatients versus healthy control
subjects for mean choline, IQ, and PSWQ. Only values for mean
choline (and not values for right and left CHO) were available.
Sex, weight, age, and study (Study #1 versus Study #2) distribu-
tions were examined for group differences and,where appropriate,
were controlled for. Pearson partial correlation matrices exam-
ined the relationship between IQ, mean choline, and PSWQ in
all subjects. GAD patients with trauma were excluded from this
analysis as trauma has been shown to produce an effect on mean
choline for subcortical white matter which can be distinguished
fromGADwithout early trauma (Coplan et al., 2006). To integrate
the inter-correlations between IQ, PSWQ, and mean CHO into a
single analysis, a Friedman’s ANOVA and the Kendall coefﬁcient
of concordance were employed.
To examine the relationship between IQ and PSWQ as a func-
tion of group assignment, a general linear model was employed
using a factorial design with group as a categorical variable, IQ as
a continuous predictor variable and the interaction between group
and IQ as the interactive variable. GAD plus trauma subjects were
included in this analysis because trauma has not been shown to
affect IQ or worry score as it does CHOmetabolism (Coplan et al.,
2006).
RESULTS
ANALYSIS OF INDEPENDENT VARIABLES IN GAD PATIENTS AND
HEALTHY VOLUNTEERS
No signiﬁcant group effect was observed for age [GAD
group mean= 36.5± 12.6 years (SD); Healthy Volunteer group
mean= 38.0± 13.2 years], weight [GAD group mean= 159.3±
FIGURE 1 |Voxel placement for centrum semiovale (CSO) white matter;
(A) MRI depicting the location of the four oblique brain sections
investigated; (B) Coronal view from second oblique section overlaid with
left and right grids of CSO voxels of interest. (C) MR spectrum from the
shaded CSO voxel in the grid shown in (B). NAA, N-acetyl-aspartate; tCho,
total choline containing compounds; tCr, total creatine+ phosphocreatine.
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39.1 lb (SD); Healthy Volunteer group mean= 151.2± 42.0 lb],
or sex and these were not used as control variables in par-
tial correlation analyses (see Tables 1 and 2). Although the two
groups did not differ with respect to age, because there was a
difference in age distribution between the two studies [Study
#1 mean= 40.0± 13.4 years; Study #2 mean= 32.1± 9.9 years;
F(1, 41)= 4.08; p = 0.04], study number was used as a covariate.
Also, because mean choline was noted to increase with increas-
ing age (r = 0.37; N = 44; p = 0.012), age was used as a covariate.
Patients with GAD reported signiﬁcantly more worry, exhibited
higher IQ scores, and showed reduced concentrations of choline-
containing compounds in the subcortical white matter voxels
(see Table 1).
CORRELATIONS AMONG MEAN CHOLINE, IQ, AND WORRY
Controlling for age and study, analyses revealed signiﬁcant
inverse correlations between mean choline and both IQ and
PSWQ scores (see Table 3). The combined effect for these
inter-correlations was highly signiﬁcant [Friedman ANOVA Chi
Square (N = 36, df = 2)= 72.00; p< 0.00001; Kendall Coeff. of
Concordance= 1.0000 Aver. rank r = 1.0000].
There were no signiﬁcant group× choline interactions for
either IQ or PSWQ when covarying for age and study. For PSWQ,
the group× choline interaction was [F(1, 36)= 2.17; p = 0.15].
For IQ, a trend for a group× choline interaction was observed
[F(1, 36)= 3.76; p = 0.06]. Upon inspection of the individual
groups’ correlations between mean choline and IQ; in GAD
patients a very weak non-signiﬁcant inverse correlation was noted
(r =−0.13; p = 0.6) whereas for the healthy volunteers a non-
signiﬁcant positive correlation was noted (r = 0.38; p = 0.13). As
the correlations were non-signiﬁcant in both groups, and the
Table 1 | Comparison of means and SDs for patients with generalized
anxiety disorder versus healthy volunteers.
GAD (N = 26) HV (N = 18) t -Value df p
Age (years) 36.54± 12.55 38.00± 13.19 −0.37 42 0.712
Weight (lb) 159.27± 39.09 151.19± 42.00 0.65 42 0.517
IQ 118.65± 9.31 109.44± 14.28 2.59 42 0.013
PSWQ 64.38± 8.64 30.06± 8.27 13.18 42 0.000
Mean choline 1.30± 0.24 1.47± 0.19 −2.55 42 0.015
GAD, generalized anxiety disorder patients; HV, healthy volunteers; df, degrees
of freedom; IQ, intelligence quotient; PSWQ, Penn StateWorry Questionnaire.
Table 2 |Two-by-two tables comparing distributions between sexes
for diagnostic groups.
HV GAD Sex
Male 8 12 20
Female 10 14 24
Group 18 26 44
HV, healthy volunteers; GAD, generalized anxiety disorder, Chi-squared= 0.01,
p= 0.9109.
group× choline interaction was a trend, there is not sufﬁcient
grounds to make an interpretation of this data. However, when
the groups are combined, signiﬁcant effects, which are presented
in Table 3, are observed.
RELATIONSHIP BETWEEN IQ AND WORRY
The groups differed with respect to the relationship between IQ
and worry scores. In GAD patients, high IQ was associated with
a greater degree of worry (r = 0.46; p = 0.016). In healthy volun-
teers,high IQwas associatedwith a relatively lower degree of worry
(r =−0.60; p = 0.009). The correlation between IQ andworrywas
signiﬁcant in both the GAD group and the healthy control group.
However, in the former, the correlation was positive and in the lat-
ter, the correlation was negative (see Figure 2). Effects remained
signiﬁcant when covarying for age and study number.
A full factorial general linear design with group and IQ as
predictor variables and PSWQ score as the dependent variable
revealed an interaction between group and IQ in predicting PSWQ
score (see Table 4).
DISCUSSION
Results from the original study were reported with the limitation
that the sample size was small and that the IQ scoresmay have been
spuriously elevated in the GAD group compared to the control
group. In this extended study, the sample size has been increased,
thusmaking these resultsmore robust than those from the original
study. It should be noted, however, that even with the increased
sample size, the mean IQ for the GAD group was elevated in com-
parison to the control group (a mean of ∼119 versus a mean of
∼109). Further, the IQ means for both the GAD group and the
control group were signiﬁcantly higher than the average IQ of
the general population (∼100). Results should thus be interpreted
with the consideration that the study sample is non-representative
of the general population.
It should furthermore be noted that differences in the neural
substrates of intelligence have been observed in men and women
(Haier et al., 2005). In our study, male and female subjects were
combined into a single analysis in order to increase sample size,
and this is a potential limitation of the study. The nature of sex
differences as they relate to intelligence, anxiety, and white matter
metabolism should be characterized in future studies.
Table 3 | Partial correlation matrix analyzing for relationship between
IQ, worry, and centrum semiovale white matter choline; GAD plus
early trauma excluded, age and study number used as covariates.
Mean choline IQ PSWQ
Mean choline 1.0000
p = –
IQ −0.5620 1.0000
p = 0.001 p = –
PSWQ −0.4223 0.1777 1.0000
p = 0.013 p = 0.315 p = –
IQ, intelligence quotient; PSWQ, Penn StateWorry Questionnaire.
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FIGURE 2 | Scatterplot of IQ versus worry in patients with GAD and healthy volunteers (Group 0=healthy volunteers, Group 1=GAD patients).
Table 4 | Full factorial general linear design with group (GAD versus
HV) and IQ as predictor variables and worry scores as the dependent
variable.
Degr. of freedom F p
Group 1; 39 6.65 0.0138
IQ 1; 39 0.14 0.7075
Group*IQ 1; 39 16.45 0.0002
Study 1; 39 3.30 0.0770
Age 1; 39 0.09 0.7643
GAD, generalized anxiety disorder; HV, healthy volunteers; IQ, intelligence
quotient, Degr., degrees, Worry scores measured by the Penn State Worry
Questionnaire, Study Number, and Age used as control variables.
Another potential limitation of the study lies in the collection
of IQ data. Only Full-scale IQ, and not the sub-indices of Verbal
IQ or Performance IQ (including Perceptual Organization), was
measured. It is possible that the various IQ sub-indices correlate
uniquely with worry and with levels of white matter CHO. This
issue should be further investigated.
With these caveats in mind, in this extended sample, we have
replicated our results tying human intelligence to pathological
worry (Coplan et al., 2006). Patients with generalized anxiety
exhibited, along with the expected increase in self-reported worry,
relatively high IQ scores and lower white matter choline and
choline-containing compounds in comparison to healthy volun-
teers. When considering all subjects except those with early life
trauma, white matter CHO concentrations correlated inversely
with both IQ and worry scores. We have previously hypothesized
that low white matter CHO represents a depletion of metabolic
substrate (Dawson et al., 1985; Duc et al., 1997). As such, subcor-
tical white matter metabolic activity may represent a functional
neuro-evolutionary commonality for both intelligence and worry.
That is, one region of the brain – the white matter – that has
contributed to the evolutionary success of humans may also be
implicated in anxiety disorders.
Pathological anxiety has heretofore been considered maladap-
tive: it represents a response to distal or potential threats that are
deemed either entirely symbolic or extremely unlikely to present
actual danger to the individual (for a review, see Grillon, 2008).
But, if high anxiety ismaladaptive, then it should not correlate pos-
itively with intelligence, the most adaptive trait for humans, as we
have shown in this study. With respect to humans exhibiting high
intelligence in this sample, we have demonstrated the presence of
two distinct phenotypes: individuals diagnosed with GAD show-
ing a high degree of pathological worry and healthy individuals
exhibiting a low degree of worry. So, we propose that the socially
based evolution of humans may actually favor the expression of
alleles responsible for high anxiety andworry.While an intelligent,
non-anxious person can assess that a distal threat is exceedingly
remote, the worrying individual is adapted to never entirely aban-
don the possibility of danger and, as a result, may adopt certain
avoidance behavioral patterns. It is possible that adaptations that
favor involuntary imposition of such avoidance patternsmay limit
potentially dangerous social contact or situations (Gilbert, 2001),
and the induction of anxious cognitions of impending catastrophe
may thereby represent a viable human phenotype.
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The results of our study call to mind recent research done by
Cochran et al. (2006) in which investigators concluded that the
social environment in medieval Europe allowed for the natural
selection of high intelligence in the Ashkenazi Jewish population.
That is, the restriction of Jews to managerial and commerce pro-
fessions that required intellectual acumen created a high ﬁtness
payoff to increased verbal and mathematical intelligence, and, as
a result, the intelligence of the Ashkenazi population increased
over the ensuing 1000 years. Researchers further proposed that the
genetic mutations in sphingolipids and DNA repair that, in their
homozygous forms, result in devastating diseases such as Tay–
Sachs may actually promote neuronal growth and connectivity in
heterozygous carriers thereby increasing intelligence.
In conclusion, we are able to demonstrate activation of
a common neural substrate, the subcortical white matter,
which varies parametrically with both anxiety and worry in a
positive manner. This suggests that what we have labeled as
maladaptive – pathological anxiety – co-evolvedwith the attribute
that is viewed as most adaptive, human intelligence.
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